scispace - formally typeset
M

Mar Larrosa

Researcher at European University of Madrid

Publications -  80
Citations -  7148

Mar Larrosa is an academic researcher from European University of Madrid. The author has contributed to research in topics: Gut flora & Resveratrol. The author has an hindex of 39, co-authored 73 publications receiving 5928 citations. Previous affiliations of Mar Larrosa include University of Florence & Spanish National Research Council.

Papers
More filters
Journal ArticleDOI

Biological significance of urolithins, the gut microbial ellagic Acid-derived metabolites: the evidence so far.

Juan Carlos Espín, +3 more
- 28 May 2013 - 
TL;DR: Preliminary evidence is shown of the anti-inflammatory, anticarcinogenic, antiglycative, antioxidant, and antimicrobial effects of urolithins, supporting their potential contribution to the health effects attributed to pomegranate and ellagitannin-rich foods.
Journal ArticleDOI

The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway.

Mar Larrosa, +2 more
- 01 Sep 2006 - 
TL;DR: This study suggests that the anticarcinogenic effect of dietary ETs could be mainly due to their hydrolysis product, EA, which induced apoptosis via mitochondrial pathway in colon cancer Caco-2 cells but not in normal colon cells.
Journal ArticleDOI

Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism

Mar Larrosa, +8 more
- 01 Aug 2010 - 
TL;DR: The results suggest that UROA could be the most active anti-inflammatory compound derived from pomegranate ingestion in healthy subjects, whereas in colon inflammation, the effects could be due to the nonmetabolized ellagitannin-related fraction.
Journal ArticleDOI

Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence.

Joao Tomé-Carneiro, +5 more
- 03 Sep 2013 - 
TL;DR: This review will focus on the currently available evidence regarding resveratrol’s effects on humans obtained from randomized clinical trials and provide a critical outlook for further research on this molecule that is evolving from a minor dietary compound to a possible multi-target therapeutic drug.
Journal ArticleDOI

Ellagitannins, ellagic acid and vascular health

Mar Larrosa, +3 more
- 01 Dec 2010 - 
TL;DR: The role of ellagitannins and ellagic acid on vascular health is critically discussed, with good evidence supporting the vascular effects in vitro and the evidence on animal models or humans is much scarcer.